Cargando…
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study
BACKGROUND: In the secondary prevention of cardiovascular (CV) disease in patients with diabetes, an optimal level of HbA1c, the most widely-used glycemic control indicator, for favorable clinical consequences still remains to be established. This study assessed the association between preprocedural...
Autores principales: | Funamizu, Takehiro, Iwata, Hiroshi, Nishida, Yuya, Miyosawa, Katsutoshi, Doi, Shinichiro, Chikata, Yuichi, Shitara, Jun, Endo, Hirohisa, Wada, Hideki, Naito, Ryo, Ogita, Manabu, Dohi, Tomotaka, Kasai, Takatoshi, Okazaki, Shinya, Isoda, Kikuo, Miyauchi, Katsumi, Daida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027034/ https://www.ncbi.nlm.nih.gov/pubmed/32070335 http://dx.doi.org/10.1186/s12933-020-00996-8 |
Ejemplares similares
-
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis
por: Chikata, Yuichi, et al.
Publicado: (2022) -
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10‐year follow‐up study
por: Nishiyama, Hiroki, et al.
Publicado: (2022) -
A Prognostic Merit of Statins in Patients with Chronic Hemodialysis after Percutaneous Coronary Intervention—A 10-Year Follow-Up Study
por: Funamizu, Takehiro, et al.
Publicado: (2022) -
Temporal Trends in Clinical Outcomes Following Percutaneous Coronary Intervention in Patients with Renal Insufficiency
por: Naito, Ryo, et al.
Publicado: (2016) -
Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010
por: Naito, Ryo, et al.
Publicado: (2017)